2298: hVIVO: Staying Resilient and Ready – CEO Mo Khan on 2025 Performance and the Road Ahead

episode

The Vox Markets Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

2026-09-23- KSR - Hour 2 51 min · 23 Sep 2026 · KSR

Kevin Harlan Is As Good As Anyone In Football | Hour 2 36 min · 23 Sep 2026 · The Dan Le Batard Show

12PM ET 09/23/2026 Newscast 3 min · 23 Sep 2026 · Fox News Hourly Update

2026-09-23- KSR - Hour 1 51 min · 23 Sep 2026 · KSR

A Dreamy Journey with a Dragon 56 min · 23 Sep 2026 · Get Sleepy: stories for sleep

American Idol Murder Trial: Wife’s Family Testifies, “We Loved Caleb So Much, We Didn’t Question Anything” 32 min · 23 Sep 2026 · Amy Robach & T.J. Holmes Present

Report any issue

Source

Recorded29 Jan 2026

Publisheraudioboom.com ↗

Handlerec:15573268

Show notes

In this exclusive conversation, hVIVO CEO Yamin ‘Mo’ Khan joins us to discuss the company’s FY2025 trading update, which delivered revenue in line with expectations and adjusted EBITDA ahead of guidance. Mo reflects on the successful integration of CRS and Cryostore, the company’s strategic repositioning beyond human challenge trials, and how hVIVO is navigating a shifting clinical research landscape. With momentum building across all service lines, Mo also shares what investors can look forward to in 2026.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in